Showing results (431-440 of 586) with videos related to

Sort By:
Pageof 59
Journal of Clinical Ultrasound : JCU|January 1, 1995
Acceleration time in normal fetal umbilical artery at term and its relationship to the cord blood hematocritF M Chang, B L Yao, C H Yu, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 17, 2010
Para-phenylenediamine induced DNA damage and apoptosis through oxidative stress and enhanced caspase-8 and -9 activities in Mardin-Darby canine kidney cellsS C Chen, C H Chen, Y L Tioh, et al.
Lab on a Chip|July 4, 2014
A light-sheet microscope compatible with mobile devices for label-free intracellular imaging and biosensingTsung-Feng Wu, Tony Minghung Yen, Yuanyuan Han, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 13, 2005
Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancerY S Lin, C C Tzeng, K F Huang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factorY S Lin, C Nguyen, J L Mendoza, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 1, 1993
Prediction of fetal macrosomia by single ultrasonic fetal biometryC P Chen, F M Chang, C H Chang, et al.
Cellular Immunology|April 15, 1999
Requirement of I-E molecule for thymocyte apoptosis induced by staphylococcal enterotoxin B in vivoY S Lin, Y T Huang, P S Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1992
In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin BY S Lin, H Y Lei, T L Low, et al.
Journal of Veterinary Internal Medicine|January 15, 2014
Neutrophil gelatinase-associated lipocalin in dogs with naturally occurring renal diseasesW-L Hsu, Y-S Lin, Y-Y Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.
Pageof 59